Related Experiment Videos
Is it Kawasaki disease?
P McMaster1, S Cooper, D Isaacs
1Department of Immunology and Infectious Diseases, Royal Alexandra Hospital for Children, Westmead, New South Wales, Australia. Paddy_McMaster@compuserve.com
Insights
Atypical Kawasaki disease (KD) requires prompt diagnosis and treatment to prevent coronary artery aneurysms. Early intravenous immunoglobulin (IVIG) is crucial for preventing cardiac complications in high-risk infants and children.
Area of Science:
- Pediatrics
- Immunology
- Cardiology
Background:
- Kawasaki disease (KD) is a critical pediatric illness.
- Atypical presentations occur in up to 10% of cases, complicating diagnosis.
- Prompt recognition is vital to prevent severe cardiac sequelae.
Observation:
- Diagnosis of KD should be considered even with incomplete classic criteria.
- Intravenous immunoglobulin (IVIG) administration is effective in preventing coronary artery dilation and aneurysms.
- High-risk indicators for coronary artery disease include age (<6 months), elevated platelet counts, high erythrocyte sedimentation rate (ESR), and prolonged fever (>2 weeks).
Findings:
- Atypical KD cases are prevalent and necessitate clinical vigilance.
- Early IVIG intervention significantly reduces the risk of coronary artery dilation.
- Specific demographic and laboratory markers identify high-risk KD patients.
Implications:
- Timely diagnosis and treatment of atypical KD are essential for preventing long-term cardiac morbidity.
- Early IVIG administration is a cornerstone of KD management, particularly in at-risk populations.
- Understanding high-risk factors aids in targeted therapeutic strategies and monitoring for Kawasaki disease.
Abstract:
Atypical cases of KD are common (up to 10% of the total) and the diagnosis should be considered without the full complement of diagnostic criteria. The risk of coronary dilation is high if IVIG is not given. Administration of IVIG is effective at preventing aneurysms, if given early. The high-risk groups for coronary artery disease are infants younger than 6 months of age and older children with very high platelet counts, high ESR and fever persisting for more than 2 weeks.